Nasdaq13d
Genevant Sciences and Arbutus Biopharma File International Lawsuits Against Moderna for Patent Infringement of Lipid Nanoparticle Technology
Evidence from tested commercial products indicates that Moderna's LNPs fall under Genevant and Arbutus's patents. The actions expand on an ongoing case in the U.S. regarding similar infringement ...
FXEmpire.com12d
Arbutus files patent infringement lawsuit against Moderna
Sun, 09 Mar 2025 05:55:04 GMT (Reuters) - Arbutus Biopharma Corp said on Monday it had filed a lawsuit against Moderna Inc seeking damages for infringement of patents related to its COVID-19 vaccine.
The Business Journals7d
Moderna suffers setback in vaccine patent battle with Pfizer
Before that, Moderna (NYSE: MRNA) had filed a patent infringement lawsuit against ... Pennsylvania firm Arbutus Biopharma Corp. (Nasdaq: ABUS) and its affiliate Genevant Sciences filed a lawsuit ...
Fierce Pharma12d
Arbutus, Genevant expand COVID patent feud with Moderna with 5 international lawsuits
Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...
Genevant, Arbutus initiate patent infringement actions against Moderna
Genevant Sciences and Arbutus Biopharma (ABUS) filed five international lawsuits seeking to enforce patents protecting their innovative LNP ...
Yahoo Finance13d
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
which upon later choice of Genevant and Arbutus can include surrender of profits, damages or a reasonable royalty, for infringement of EP 2 279 254. Unified Patent Court (UPC): Case 10280/2025 ...
Financial Post14d
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
Switzerland: filing a case seeking a permanent injunction and monetary relief, which upon later choice of Genevant and Arbutus can include surrender of profits, damages or a reasonable royalty, for ...